WHO suspension: Shantha says no safety issue with pentavalent vaccine
17 March 2010
Anju Ghangurde
Please Login to read the full article.
17 March 2010
Anju Ghangurde
Shantha Biotechnics has said that investigations conducted so far by its Q&A cell and the World Health Organization (WHO) suggest that there is "no safety issue" with its pentavalent vaccine, Shan5, procurement of which has been temporarily suspended by the WHO.
The WHO had, last...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Shantha's pentavalent vaccine seen back in global bidding process soon
- Panacea in stock spiral as WHO disqualifies three vaccines
- Indian vaccines overhaul needed to counter China competion and shaming paradox
- GSK, Merck and Indian firms slash childhood vaccine prices for GAVI/UNICEF
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
